Epigenome editing therapeutics for chronic diseases
At a glance
- HQ: Durham
- Sector: Biotech
- Stage: Series B
- Total raised: $215M
- Last round: Series B
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Listed roles
All Triangle rolesChecking listed roles…